Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital  An observational study

Shashank A Desai; Dinesh K Dhodi; Shyamal R Sinha

doi:10.5455/njppp.2021.11.10290202031102020

2024, Vol: 14, Issue: 10

14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 11 Nov 2020

Natl J Physiol Pharm Pharmacol. 2021; 11(3): 263-268

doi: 10.5455/njppp.2021.11.10290202031102020

Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study

Shashank A Desai, Dinesh K Dhodi, Shyamal R Sinha.

Abstract
Background: Adverse drug reactions (ADRs) are regarded as one of the major causes of non-adherence to anti-tuberculosis (TB) treatment. Identify ADRs and Establish a causal relationship between Suspected drug and Adverse Event is very important step from Pharmacovigilance point of view.

Aim and Objective: This study aims to monitor the adverse effects of the drugs in the patients on treatment for TB and do the causality assessment.

Materials and Methods: A prospective, single-centric, observational, and open-labeled study was carried out in a tertiary care hospital of Mumbai. Patients presenting with ADRs were monitored, analyzed and causality assessment was carried out using World Health Organization-Uppsala Monitoring Centre (WHO-UMC) and Naranjos assessment scale.

Results: A total of 459 patients presenting with ADRs were enrolled in the study, their mean age was 34.60±14.21 years while male patients outnumbered female patients. About 363 patients presented with at least any one type of ADR followed by 96 patients presented with combination of any two ADRs, so study population (n = 459) presented with total 555 ADRs. Gastrointestinal and hepatobiliary system were the most affected sites of body. Majority of ADRs showed possible relation to the suspected drug during causality assessment using both the WHO-UMC and Naranjos scale.

Conclusion: Majority of ADRs were mild to moderate in nature with no occurrence of severe ADR. It is important to establish information management systems to detect and report adverse drug events in chronic infective respiratory disease like TB. Focus should be given on assessment and prevention of medication errors resulting in ADRs.

Key words: Adverse Drug Reaction; Causality Assessment; Naranjos Algorithm; World Health Organization-Uppsala Monitoring Centre Scale

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Shashank A Desai Articles by Dinesh K Dhodi Articles by Shyamal R Sinha
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Desai SA, Dhodi DK, Sinha SR. Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. Natl J Physiol Pharm Pharmacol. 2021; 11(3): 263-268. doi:10.5455/njppp.2021.11.10290202031102020

Web Style

Desai SA, Dhodi DK, Sinha SR. Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. https://www.njppp.com/?mno=21680 [Access: November 02, 2024]. doi:10.5455/njppp.2021.11.10290202031102020

AMA (American Medical Association) Style

Desai SA, Dhodi DK, Sinha SR. Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. Natl J Physiol Pharm Pharmacol. 2021; 11(3): 263-268. doi:10.5455/njppp.2021.11.10290202031102020

Vancouver/ICMJE Style

Desai SA, Dhodi DK, Sinha SR. Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. Natl J Physiol Pharm Pharmacol. (2021), [cited November 02, 2024]; 11(3): 263-268. doi:10.5455/njppp.2021.11.10290202031102020

Harvard Style

Desai, S. A., Dhodi, . D. K. & Sinha, . S. R. (2021) Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. Natl J Physiol Pharm Pharmacol, 11 (3), 263-268. doi:10.5455/njppp.2021.11.10290202031102020

Turabian Style

Desai, Shashank A, Dinesh K Dhodi, and Shyamal R Sinha. 2021. Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (3), 263-268. doi:10.5455/njppp.2021.11.10290202031102020

Chicago Style

Desai, Shashank A, Dinesh K Dhodi, and Shyamal R Sinha. "Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 263-268. doi:10.5455/njppp.2021.11.10290202031102020

MLA (The Modern Language Association) Style

Desai, Shashank A, Dinesh K Dhodi, and Shyamal R Sinha. "Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study." National Journal of Physiology, Pharmacy and Pharmacology 11.3 (2021), 263-268. Print. doi:10.5455/njppp.2021.11.10290202031102020

APA (American Psychological Association) Style

Desai, S. A., Dhodi, . D. K. & Sinha, . S. R. (2021) Causality assessment of adverse drug reactions reported with antitubercular drugs in a tertiary care hospital An observational study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (3), 263-268. doi:10.5455/njppp.2021.11.10290202031102020

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article